Estrogen-like activity and dual roles in cell signaling of an Agaricus blazei Murrill mycelia-dikaryon extract

Microbiological Research

Volumn 167, Issue 4, 2012, Pages 231-237

  Dong, Sijun ^a,b   Furutani, Yoshiyuki ^a   Suto, Yumiko ^a   Furutani, Michiko ^a   Zhu, Yun ^e   Yoneyama, Makoto ^c   Kato, Taichi ^a   Itabe, Hiroyuki ^d   Nishikawa, Toshio ^a   Tomimatsu, Hirofumi ^a   Tanaka, Takeshi ^a   Kasanuki, Hiroshi ^a   Masaki, Tomoh ^a   Kiyama, Ryoiti ^e   Matsuoka, Rumiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c Fungi Engineering Section   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Agaricus blazei Murrill; Estrogenic activity; OxLDL; Signal transduction

Indexed keywords

DISEASES; ENDOTHELIAL CELLS; GENES; MACROPHAGES; PLANTS (BOTANY); SIGNAL TRANSDUCTION; TRANSCRIPTION;

AGARICUS BLAZEI; ATHEROSCLEROTIC LESIONS; CELL SIGNALING; DUAL ROLE; ESTROGENIC ACTIVITIES; GENE EXPRESSION PROFILING; GLUTATHIONE PEROXIDASE; LOW DENSITY; LUCIFERASE ASSAYS; MECHANISM OF ACTION; OXLDL; SYNTHASES; SYNUCLEIN; VASCULAR DAMAGE;

MOLECULAR BIOLOGY;

CANCER; DISEASE TREATMENT; ENZYME ACTIVITY; ESTROGENIC COMPOUND; GENE EXPRESSION; GENETIC ENGINEERING; INHIBITION; LAGOMORPH; LESION; MOLECULAR ANALYSIS; MUSHROOM; PATHOLOGY; PROTEIN;

AGARICUS BLAZEI; ORYCTOLAGUS CUNICULUS;

EID: 84863229530     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2011.09.003     Document Type: Article

References (45)

1. Baker L., Meldrum K.K., Wang M., Sankula R., Vanam R., Raiesdana A., et al. The role of estrogen in cardiovascular disease. J Surg Res 2003, 115:325-344.
2. Barbisan L.F., Scolastici C., Miyamoto M., Salvadori D.M., Ribeiro L.R., da Eira A.F., et al. Effects of crude extracts of Agaricus blazei on DNA damage and on rat liver carcinogenesis induced by diethylnitrosamine. Genet Mol Res 2003, 30:295-308.
3. Cassidy A., Bingham S., Setchell K.D. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1999, 60:333-340.
4. Cassidy A., de Pascual Teresa S., Rimbach G. Molecular mechanisms by which dietary isoflavones potentially prevent atherosclerosis. Expert Rev Mol Med 2003, 5:1-15.
5. Chen X.P., Zhang T.T., Du G.H. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?. Cardiovasc Drug Rev 2007, 25:146-161.
6. Clarkson T.B. Soy, soy phytoestrogens and cardiovascular disease. J Nutr 2002, 132:566S-569S.
7. Deng R. Food and food supplements with hypocholesterolemic effects. Recent Pat Food Nutr Agric 2009, 1(1):15-24.
8. Endo M., Beppu H., Akiyama H., Wakamatsu K., Ito S., Kawamoto Y., et al. Agaritine purified from Agaricus blazei Murrill exerts anti-tumor activity against leukemic cells. Biochim Biophys Acta 2010, 1800:669-673.
9. Farhat M.Y., Lavigne M.C., Ramwell P.W. The vascular protective effects of estrogen. FASEB J 1996, 10:615-624.
10. Faxon D.P., Fuster V., Libby P., Beckman J.A., Hiatt W.R., Thompson R.W., et al. Atherosclerotic vascular disease conference: writing group III: pathophysiology. Circulation 2004, 109:2617-2625.
11. Firenzuoli F., Gori L., Lombardo G. The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmaco-toxicological problems. Evid Based Complement Alternat Med 2008, 5(1):3-15.
12. Grube B.J., Eng E.T., Kao Y.C., Kwon A., Chen S. White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J Nutr 2001, 131:3288-3293.
13. Guterrez Z.R., Mantovani M.S., Eira A.F., Ribeiro L.R., Jordão B.Q. Variation of the antimutagenicity effects of water extracts of Agaricus blazei Murrill in vitro. Toxicol In Vitro 2004, 18:301-309.
14. Harrington J.R. The role of MCP-1 in atherosclerosis. Stem Cells 2000, 18(1):65-66.
15. Hisamoto K., Ohmichi M., Kanda Y., Adachi K., Nishio Y., Hayakawa J., et al. Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal-regulated protein kinase in vascular endothelial cells. J Biol Chem 2001, 276:47642-47649.
16. Inoue A., Hayashi S., Aoyagi K., Nishigaki M., Sasaki H., Kiyama R. A reporter gene assay for evaluation of tissue-specific responses to estrogens based on the differential use of promoters A to F of the human estrogen receptor alpha gene. J Pharmacol Toxicol Methods 2002, 47(3):129-135.
17. Itabe H., Yamamoto H., Imanaka T., Shimamura K., Uchiyama H., Kimura J., et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res 1996, 37:45-53.
18. Itoh H., Ito H., Amano H., Noda H. Inhibitory action of a (1(6)-β-d-glucan-protein complex) (F III-2-b) isolated from Agaricus blazei Murill (himematsutake) on Meth A fibrosarcoma-bearing mice and its antitumor mechanism. Jpn J Pharmacol 1994, 66:265-271.
19. Kalin M.F., Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids 1990, 55:330-352.
20. Kaneno R., Fontanari L.M., Santos S.A., Di Stasi L.C., Rodrigues Filho E., Eira A.F. Effects of extracts from Brazilian sun-mushroom (Agaricus blazei) on the NK activity and lymphoproliferative responsiveness of Ehrlich tumor-bearing mice. Food Chem Toxicol 2004, 42:909-916.
21. Kawagishi H., Inagaki R., Kanao T., Mizuno T., Shimura K., Ito H., et al. Fractionation and antitumor activity of the water-insoluble residue of Agaricus blazei fruiting bodies. Carbohydr Res 1989, 186:267-273.
22. Klinge C.M., Blankenship K.A., Risinger K.E., Bhatnagar S., Noisin E.L., Sumanasekera W.K., et al. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem 2005, 280:7460-7468.
23. Kobayashi H., Masumoto J. Endotoxin contamination of Agaricus blazei Murrill extract enhances murine immunologic responses and inhibits the growth of sarcoma 180 implants in vivo. J Environ Pathol Toxicol Oncol 2010, 29(2):159-168.
24. Lieberman E.H., Gerhard M.D., Uehata A., Selwyn A.P., Ganz P., Yeung A.C., et al. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol 1996, 78:1210-1214.
25. Ludmer P.L., Selwyn A.P., Shook T.L., Wayne R.R., Mudge G.H., Alexander R.W., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1996, 315:1046-1051.
26. Mendelsohn M.E. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002, 89:12E-17E.
27. Mendelsohn M.E. Estrogen actions in the cardiovascular system. Climacteric 2009, 12(Suppl. 1):18-21.
28. Mendelsohn M.E., Karas R.H. Estrogen and the blood vessel wall. Curr Opin Cardiol 1994, 9:619-626.
29. Mendelsohn M.E., Karas R.H. Rapid progress for non-nuclear estrogen receptor signaling. J Clin Invest 2010, 120(7):2277-2279.
30. Nathan L., Chaudhuri G. Estrogens and atherosclerosis. Annu Rev Pharmacol Toxicol 1997, 37:477-515.
31. Oliveira Lima C.U., de Almeida Cordova C.O., de Tolêdo Nóbrega O., Funghetto S.S., de Oliveira Karnikowski M.G. Does the Agaricus blazei Murill mushroom have properties that affect the immune system? An integrative review. J Med Food 2011, 14(1-2):2-8.
32. O'Lone R., Knorr K., Jaffe I.Z., Schaffer M.E., Martini P.G., Karas R.H., et al. Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species. Mol Endocrinol 2007, 21:1281-1296.
33. Patten R.D., Pourati I., Aronovitz M.J., Baur J., Celestin F., Chen X., et al. 17β-Estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 2004, 95:692-699.
34. Pinheiro F., Faria R.R., de Camargo J.L., Spinardi-Barbisan A.L., da Eira A.F., Barbisan L.F. Chemoprevention of preneoplastic liver foci development by dietary mushroom Agaricus blazei Murrill in the rat. Food Chem Toxicol 2003, 41:1543-1550.
35. Raines E.W., Ross R. Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the potential impact of soy. J Nutr 1995, 125:624S-630S.
36. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995, 57:791-804.
37. Sanborn T.A., Faxon D.P., Waugh D., Small D.M., Haudenschild C., Gottsman S.B., et al. Transluminal angioplasty in experimental atherosclerosis. Analysis for embolization using an in vivo perfusion system. Circulation 1982, 66:917-922.
38. Senokuchi T., Matsumura T., Sakai M., Matsuo T., Yano M., Kiritoshi S., et al. Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein. Atherosclerosis 2004, 176:233-245.
39. Talorete T.P., Isoda H., Maekawa T. Agaricus blazei (class Basidiomycotina) aqueous extract enhances the expression of c-Jun protein in MCF7 cells. J Agric Food Chem 2002, 28:5162-5166.
40. Terasaka S., Aita Y., Inoue A., Hayashi S., Nishigaki M., Aoyagi K., et al. Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ Health Perspect 2004, 112:773-781.
41. Terasaka S., Inoue A., Tanji M., Kiyama R. Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity. Toxicol Lett 2006, 163:130-141.
42. Tham D.M., Gardner C.D., Haskell W.L. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998, 83:2223-2235.
43. White R.E. Estrogen and vascular function. Vascul Pharmacol 2002, 38:73-80.
44. Yano M., Matsumura T., Senokuchi T., Ishii N., Motoshima H., Taguchi T., et al. Troglitazone inhibits oxidized low-density lipoprotein-induced macrophage proliferation: impact of the suppression of nuclear translocation of ERK1/2. Atherosclerosis 2007, 191:22-32.
45. Zhao C., Dahlman-Wright K., Gustafsson J.Å. Estrogen signaling via estrogen receptor β. J Biol Chem 2010, 285(51):39575-39579.